Results 61 to 70 of about 3,132,176 (310)

Outcomes of systemic treatment in advanced melanoma after progression on anti–PD-1 therapy: a real-world study with literature review

open access: yesOncology in Clinical Practice
INTRODUCTION: Currently, a substantial proportion of patients are still treated with first-line anti-PD-1 immunotherapy (ICI). After disease progression, treatment options, especially for patients with BRAF-negative tumors, are limited.
Piotr J. Błoński   +8 more
doaj   +1 more source

Epithelioid sarcoma

open access: yesNowotwory, 2023
Epithelioid sarcoma (ES) is a very rare sarcoma characterized by loss of INI1. Enzinger first described ES in 1970, butthe histopathologic differential diagnosis of ES remains challenging.
Anna M. Czarnecka
doaj   +1 more source

Treatment pattern of extremity soft tissue sarcoma.

open access: yes, 2015
Treatment pattern of extremity soft tissue sarcoma.
Seungcheol Kang (779102)   +2 more
core   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Bone and Soft Tissue Sarcoma [PDF]

open access: yesCancers, 2020
Bone and soft-tissue sarcomas are relatively rare tumors both in children and adults [...]
openaire   +2 more sources

Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedin

open access: yesScientific Reports
Trabectedin is a chemotherapeutic agent that has shown activity in the treatment of patients with soft tissue sarcomas after failure of anthracycline-based therapy and the best results were recorded in the treatment of L-sarcomas.
Pawel Sobczuk   +9 more
doaj   +1 more source

Modern Dressings in Prevention and Therapy of Acute and Chronic Radiation Dermatitis—A Literature Review

open access: yesPharmaceutics, 2022
Radiotherapy is an integral part of modern oncology, applied to more than half of all patients diagnosed with cancer. It can be used alone or in combination with surgery or chemotherapy.
Konrad Zasadziński   +2 more
doaj   +1 more source

Soft tissue sarcoma subtypes in the TCGA.

open access: yes, 2019
Soft tissue sarcoma subtypes in the TCGA.
David G. P. van IJzendoorn (6384053)   +5 more
core   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

open access: yesMolecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim   +7 more
wiley   +1 more source

Soft Tissue Sarcomas

open access: yesAnnals of Surgery, 1975
One hundred fifty-five adult patients with "operable" soft part sarcomas including rhabdomyosarcoma, liposarcoma, leiomyosarcoma and fibrosarcoma of the trunk and extremities are reviewed. Local recurrences of 93% and 60% occurred after local and wide excisions of the primary tumor.
R E, Gerner, G E, Moore, J W, Pickren
openaire   +3 more sources

Home - About - Disclaimer - Privacy